Roche's Genentech goes on deal spree, unveiling third deal on the same day

The business development executives at Roche’s Genentech have been busy shopping.

After announcing tie-ups with Sosei Heptares and Skyhawk on Tuesday, Genentech unveiled yet another deal: with Cleveland-based biotech Convelo Therapeutics.